Publisher correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab (Leukemia, (2021), 35, 1, (201-214), 10.1038/s41375-020-0840-y)

Authors :: García-Guerrero, Estefanía
Götz, Ralph
Doose, Sören
Sauer, Markus
Rodríguez Gil, Alfonso
Pérez Simón, José Antonio
Danhof, Sophia
Universidad de Sevilla. Departamento de Fisiología Médica y Biofísica
Publication Year :: 2022
Publisher :: Springer Nature, 2022.

Tools